Ozempic® and burping

Eructation in the three Ozempic® documents

The US label lists burping in a short paragraph of gastrointestinal reactions that affected under 5% of people and were associated with Ozempic®. The Canadian monograph puts it in its main table, which counts anything reported by at least 1% and above the comparison group. The EU summary gives only a frequency band.

Small numbers, a clear contrast

With only around 260 people per group in the US trials, a 2.7% rate means about seven people. That is why the dose pattern is hard to read: the US pool shows more burping on 0.5 mg than on 1 mg, while the much larger Canadian pool shows a modest rise with dose ^[1][3]. The more robust finding is the gap against placebo, which runs in the same direction in both.

Burping rarely comes alone. The same US paragraph reports indigestion in 3.5% and 2.7% (1.9% on placebo) and reflux in 1.9% and 1.5% (none on placebo) for 0.5 mg and 1 mg ^[1]. MedlinePlus notes that belching can relieve nausea, indigestion and heartburn, so these complaints often travel together ^[7].

Neither document reports burping on the 2 mg dose, nor how long it lasted. The US label says only that most nausea, vomiting and diarrhoea occurred during dose escalation ^[1].

Evidence from research

In the pooled SUSTAIN analysis of 3,150 people on weekly semaglutide injections, gastrointestinal disorders as a group were most frequent while starting and increasing the dose and became less common with continued treatment ^[4]. The abstract does not report burping separately.

The EU summary adds one combination worth knowing: when semaglutide 1 mg was added to an SGLT2 inhibitor in the SUSTAIN 9 trial, reflux occurred in 4% of people and in none on placebo, and the rate did not fall over time ^[2]. A 2025 analysis of US adverse-event reports (FAERS) found that reflux was reported disproportionately often with every GLP-1 medicine studied, semaglutide included ^[6]. Spontaneous reports can flag a signal but cannot show cause or how often something happens.

Why semaglutide may make you burp

MedlinePlus explains the basic mechanics: swallowed air collects in the upper stomach, stretches it, and that stretch makes the valve at the bottom of the food pipe relax so air can escape ^[7].

What the label supports: semaglutide causes a minor delay in early stomach emptying after meals ^[2]. A 12-week trial of semaglutide 1.0 mg in 30 adults with obesity measured slower emptying in the first hour after eating, with similar total emptying over five hours ^[5].

What is plausible but unmeasured: a meal lingering in the upper stomach during that first hour could add to stretch and pressure, and so to burping. No Ozempic® study tested this, and no document explains why some people notice an unpleasant, eggy smell.

Other reasons people burp more

Cleveland Clinic lists swallowed air as the most common cause of excessive belching, alongside these ^[8]:

• Eating or drinking quickly, talking while eating, chewing gum, sucking hard sweets and fizzy drinks.
• Smoking, poorly fitting dentures, mouth breathing, snoring or using a CPAP machine.
• Foods that produce gas, such as beans, lentils, cabbage, onions and broccoli.
• Reflux, functional dyspepsia, gastroparesis, gastritis, stomach ulcers, lactose intolerance, H. pylori infection and small intestinal bacterial overgrowth.
• Air swallowing when anxious or stressed (aerophagia).

Steps MedlinePlus, Cleveland Clinic and NIH describe

For a bout of burping, MedlinePlus suggests lying on your side or in a knee-to-chest position until the gas passes, and avoiding gum, fast eating and gas-producing foods and drinks ^[7]. Cleveland Clinic adds sitting down to eat, taking your time, and cutting back on fizzy drinks and alcohol ^[8]. NIDDK suggests not drinking through a straw, not talking while eating and, if you wear dentures, checking that they fit ^[9].

Because burping and reflux overlap, note whether you also have heartburn or a sour taste. If you want an over-the-counter remedy, ask your pharmacist which one suits Ozempic® and your other medicines rather than choosing by brand name.

Ozempic® details that shape the picture

The label starts at 0.25 mg for four weeks before 0.5 mg and spaces every later increase by at least four weeks, explicitly to reduce stomach side effects ^[1]. It also warns that stomach reactions can occasionally be severe: 0.4% on 0.5 mg and 0.8% on 1 mg versus none on placebo ^[1]. MedlinePlus says a provider will ask whether this is new, whether there is a pattern, for example after certain foods or when nervous, and what else you notice ^[7], which is easy to answer if you have noted dose steps and meals.

Ozempic® is a registered trademark of Novo Nordisk A/S. PepLabo is not affiliated with or endorsed by Novo Nordisk.

When to get help